Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols

Overview of attention for article published in BMC Cancer, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 18,409 followers.

RT @MPishvaian: @deepaliamit @SirohiBhawna @GauravGangwan15 @TumorBoardTues #TumorBoardTuesday Unfortunately, still no prospective, random…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.